A preliminary double-blind cross-over trial of lio-PGI2, A prostacyclin derivative incorporated in lipid microspheres, in cerebral infarction
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 40 (2) , 155-164
- https://doi.org/10.1016/0090-6980(90)90081-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Application of Lipid Microspheres for Targeting TherapyJournal of Bioactive and Compatible Polymers, 1988
- Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial.Stroke, 1987
- Marked enhancement in antithrombotic activity of isocarbacyclin following its incorporation into lipid microspheresProstaglandins, 1987
- THE EFFECT OF PROSTAGLANDIN-E1 INCORPORATED IN LIPID MICROSPHERES ON THROMBUS FORMATION AND THROMBUS DISAGGREGATION AND ITS POTENTIAL TO TARGET TO THE SITE OF VASCULAR-LESIONS1986
- Double-blind controlled trial of the therapeutic effects of prostacyclin in patients with completed ischaemic stroke.Stroke, 1985
- Double-blind controlled trial of prostacyclin in cerebral infarction.Stroke, 1985
- Prostacyclin infusion in acute cerebral infarctionNeurology, 1984
- Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in manJournal of Pharmacy and Pharmacology, 1983
- Treatment of ischaemic stroke with prostacyclin.Stroke, 1983
- Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion.Annals of the Rheumatic Diseases, 1982